Document is current
Any future updates will be listed below
-
Authors
Nijssen, D. J. https://orcid.org/0000-0002-8360-8585
Wienholts, K. https://orcid.org/0000-0002-3898-1663
Postma, M. J. https://orcid.org/0000-0002-6306-3653
Bemelman, W. A. https://orcid.org/0000-0002-1037-9945
Tuynman, J. https://orcid.org/0000-0001-5952-8000
Laméris, W.
Tanis, P. J.
Hompes, R. https://orcid.org/0000-0001-6094-8950
,
Slooter, M. D.
Talboom, K.
van Helsdingen, C. P. M.
Petersen, A. E.
van Dieren, S.
Ponsioen, C. Y.
Consten, E. C. J.
Verheijen, P. M.
Sikkenk, D. J.
Derikx, J. P. M.
Musters, G. D.
van der Bilt, J D. M.
vsn de Ven, A. W. H,
Bloemen, J. G.
Burger, J. W. A.
Faneyte, I.
Verhagen, T.
Holzik, M. F. Lutke
Masselink, I.
Morsink, L.
Gerhards, M.
Karsten, T. M.
Festen, S.
van Dijk, S.
de Jonge, W. J.
van der Meij, W.
van Wely, B. J.
Oosterling, S. J.
Scholten, J.
Stassen, L. P, S.
Verdaasdonk, J.
Brokelman, W. J. A.
van Westreenen, H. L.
Steller, E. J. A.
van Dalsen, A. D.
de Wilt, J. H. W.
Garms, L.
Belgers, E. H. J.
Ancion, E.
Vijgen, G. H. E. J.
Heemskerk, J.
Leijtens, J. W. A.
-
Funding
Funding for this research was provided by:
Styker European Operations B.V.
- License Information
-
More Information
Article History
Received: 15 January 2025
Accepted: 26 July 2025
First Online: 8 October 2025
Declarations
:
: R.H. received grants and materials from Stryker European Operations B.V. and consultancy fees from Applied Medical. M.J.P. reports grants and honoraria from various pharmaceutical companies, all unrelated to this research, and is an advisor of Asc Academics and holds stocks from Health-Ecore and Pharmacoeconomics Advice Groningen. W.A.B. has received grants from Braun and Vifor, and has served as speaker for Takeda, Johnson and Johnson and Braun. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The authors declare no other conflicts of interest.
: This study analysed data from the IMARI-study. The IMARI-study has been approved by the Medical Ethical Committee (METC 2019_055, August 14th, 2019) and Biobank committee (METC 2019_219, February 21st, 2020) of the Amsterdam UMC, location AMC. The protocol is registered by the Dutch Central Committee on Research Involving Human Subjects (NL67600.018.18).
: Written informed consent was obtained from all participants.
